Pityriasis rubra pilaris: algorithms for diagnosis and treatment

被引:62
作者
Roenneberg, S. [1 ]
Biedermann, T. [1 ]
机构
[1] Tech Univ Munich, Dept Dermatol & Allergy Biederstein, Munich, Germany
关键词
OF-THE-LITERATURE; LONG-TERM; EXTRACORPOREAL PHOTOCHEMOTHERAPY; RETROSPECTIVE ANALYSIS; INITIAL MANIFESTATION; CLINICAL IMPROVEMENT; INFLIXIMAB TREATMENT; ORAL ALITRETINOIN; TREATMENT OPTION; USTEKINUMAB;
D O I
10.1111/jdv.14761
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Pityriasis rubra pilaris (PRP) is a rare inflammatory skin disease that affects men and women of all ages and also children. The clinical appearance of PRP is highly variable, as is the individual prognosis. Therefore, stratifying PRP into six disease subtypes represents a first step to personalized medicine for this rare inflammatory skin disease. The next step should be to associate specific therapeutic strategies with these subtypes of PRP. However, no randomized, controlled trials on the treatment of PRP have been performed. Consequently, the actual treatment algorithm for PRP will be based on clinical experience, small case series and case reports. The majority of published evidence is on type I PRP, whereas the treatment experience for other clinical types of PRP is still sparse and has to be gained. Nevertheless, it is now time to start developing valid algorithms as a basis for the diagnosis and treatment of PRP based on the data available. This review makes use of algorithms developed in psoriasis and atopic eczema and puts together recent insights into the pathogenesis, diagnosis and treatment experience of PRP. The innovative intention of this appraisal is to develop a structured algorithm for PRP treatment that should be further developed going forward.
引用
收藏
页码:889 / 898
页数:10
相关论文
共 129 条
[1]   Effectiveness of Infliximab in Pityriasis Rubra Pilaris Is Associated with Pro-Inflammatory Cytokine Inhibition [J].
Adnot-Desanlis, L. ;
Antonicelli, F. ;
Tabary, T. ;
Bernard, P. ;
Reguiai, Z. .
DERMATOLOGY, 2013, 226 (01) :41-46
[2]   Clinical improvement of pityriasis rubra pilaris with antibiotic therapy [J].
Ahn, Seok-Yong ;
Kim, Jae-Hong ;
Ahn, Sung Ku ;
Oh, Youn Seok .
EUROPEAN JOURNAL OF DERMATOLOGY, 2011, 21 (01) :106-107
[3]   Comparison of the paper-based and electronic versions of the Dermatology Life Quality Index: evidence of equivalence [J].
Ali, F. M. ;
Johns, N. ;
Finlay, A. Y. ;
Salek, M. S. ;
Piguet, V. .
BRITISH JOURNAL OF DERMATOLOGY, 2017, 177 (05) :1306-1315
[4]   Pityriasis rubra pilaris in children [J].
Allison, DS ;
el-Azhary, RA ;
Calobrisi, SD ;
Dicken, CH .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2002, 47 (03) :386-389
[5]  
Amann Philipp M, 2015, Acta Derm Venereol, V95, P329, DOI 10.2340/00015555-1928
[6]  
Avitan-Hersh E, 2015, AM J DERMATOPATH, V37, P755, DOI 10.1097/DAD.0000000000000346
[7]   Successful treatment of pityriasis rubra pilaris (type 1) under combination of infliximab and methotrexate [J].
Barth, Dietrich ;
Harth, Wolfgang ;
Treudler, Regina ;
Simon, Jan C. .
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2009, 7 (12) :1071-1073
[8]   Pityriasis rubra pilaris as the initial presentation of renal cell carcinoma? [J].
Batchelor, RJ ;
Yung, A ;
Merchant, W ;
Goodfield, MJD .
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2005, 30 (04) :442-443
[9]   Pityriasis rubra pilaris in association with laryngeal carcinoma [J].
Batinac, T. ;
Kujundzic, M. ;
Peternel, S. ;
Cabrijan, L. ;
Troselj-Vukic, B. ;
Petranovic, D. .
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2009, 34 (08) :E917-E919
[10]  
Besnier E, 1889, Ann Dermatol 2nd series, V10, P253